New microbes and new infections
Molecular evidence of a dominant multidrug resistant Acinetobacter baumannii lineage in a tertiary hospital in northern Peru
Door Quispe Choque KG, Ruiz Quiñones N, Binatti Ferreira M en 5 anderen.
Inhoud in het Engels
Abstract
Background
Acinetobacter baumannii is a major nosocomial pathogen because of its genomic plasticity and capacity to acquire multidrug resistance (MDR), particularly resistance to carbapenems. The World Health Organization classifies carbapenem-resistant A. baumannii as a critical-priority pathogen. Molecular epidemiological data from Latin America remain limited, especially for northern Peru.